Ae8.5

Artichoke Extract

Artichoke Leaf Extract (Cynara scolymus)

A digestive herb that supports bile flow, liver health, and cholesterol management.

bodydigestiveliverbilecholesterol
Last reviewed: February 1, 2025
8.5/10
39+ studies
Evidence
high
Safety
600-1200mg extract daily
Dose
4-12 weeks
Time to Effect
Standardized leaf extract (2.5-5% cynarin)
Best Form

Artichoke Leaf Extract has been used for centuries in Mediterranean traditional medicine for digestive and liver complaints. Modern research confirms its benefits for indigestion, stimulating bile production, supporting liver function, and modestly lowering cholesterol. The active compounds cynarin and chlorogenic acid provide its therapeutic effects.

Mechanisms of Action

💚
Bile Stimulation

Increases bile production and flow

🛡
Liver Protection

Supports liver cell health and regeneration

❀
Cholesterol Metabolism

Inhibits cholesterol synthesis

Recommended Dose

600-1200mg extract daily

300mg1800mg

Loading: Not required

Optimal Timing

  • Before meals (especially fatty meals)
  • Divided doses

Can be taken without food

Best Form

Standardized leaf extract (2.5-5% cynarin)

Alternatives: Capsules, Liquid extract

Look for extracts standardized to cynarin or caffeoylquinic acid content.

Duration

Minimum: 4 weeks

Optimal: 12 weeks

Cycling: Not required

Note: Taking before meals, especially those containing fat, helps stimulate bile for better digestion.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

👍
Improved Digestion

Reduced bloating, nausea, and indigestion

2-4 weeks
70% of users notice thispositive
❀
Cholesterol Reduction

Modest lowering of total and LDL cholesterol

8-12 weeks
55% of users notice thispositive
💚
Liver Support

Improved liver enzyme markers

4-8 weeks
50% of users notice thispositive
High SafetyMax safe dose: 1800mg/day commonly used
🟡
Those with gallstones

Consult doctor - increased bile flow could be problematic

Who Should NOT Take This

  • Bile duct obstruction
  • Gallstones (use with caution)
  • Allergy to Asteraceae plants

Drug Interactions

Statins (rosuvastatin, atorvastatin)moderate

May decrease statin bioavailability; take 2+ hours apart

Anticoagulants (warfarin, Eliquis)moderate

May affect blood clotting and increase bleeding risk

Blood pressure medicationsmild

May enhance blood pressure-lowering effects

Diabetes medicationsmild

May enhance blood sugar lowering; monitor glucose

Possible Side Effects

Increased gasuncommon

Tip: Start with lower dose

Allergic reactionrare

Tip: Avoid if allergic to daisies, ragweed, marigolds

Warnings

  • Avoid with bile duct obstruction
  • May cause allergic reactions in those sensitive to Asteraceae family

Top studies from 39+ peer-reviewed papers

meta-analysisn=702
DOI

Sahebkar A et al. • Critical reviews in food science and nutrition (2018)

“Thus, supplementation with artichoke extract was associated with a significant reduction in both total and LDL-C, and triglycerides, suggesting that supplementation may be synergistic with lipid-lowering therapy in patients with hyperlipidemia.”
Key Findings:
  • Quantitative data synthesis was performed using a random-effects model, with weighed mean difference (WMD) and 95% confidence interval (CI) as summary statistics.
  • No significant alteration in plasma High Density Lipoprotein-Cholesterol (HDL-C) concentrations was observed (WMD: 1.0 mg/dL, 95%CI: -1.1, 3.1, p = 0.333).
  • A significant association between the LDL-lowering effect of artichoke and baseline LDL-C concentrations (slope: -0.170; 95%CI: -0.288, 0.051; p = 0.005) was observed.
  • Thus, supplementation with artichoke extract was associated with a significant reduction in both total and LDL-C, and triglycerides, suggesting that supplementation may be synergistic with lipid-lowering therapy in patients with hyperlipidemia.
systematic-review
DOI

Porro C et al. • Nutrients (2024)

“The current review discussed the nutritional profiles, potential benefits, and pharmacological effects of C. scolymus.”
Key Findings:
  • This reduces the subsequent risk of developing conditions such as cancer, diabetes, and cardiovascular diseases.
  • Additionally, these polyphenols demonstrate anti-inflammatory activity, which is closely associated with their antioxidant properties.
  • As a result, C. scolymus has the potential to contribute to the treatment of chronic diseases, including intestinal disorders, cardiovascular diseases, and neurodegenerative pathologies.
  • The current review discussed the nutritional profiles, potential benefits, and pharmacological effects of C. scolymus.
systematic-review
DOI

Derosa G et al. • Phytotherapy research : PTR (2024)

“Phytotherapy Research published by John Wiley & Sons Ltd.”
Key Findings:
  • Further studies are also required for Cinnamomum, Cynara scolymus, Momordica charantia, Olea europaea, and Opuntia streptacantha.
  • Moreover, well-designed large and long-term clinical trials including the use of standardized nutraceutical preparations are necessary for Phaseolus vulgaris and Vaccinium myrtillus.© 2024 The Author(s).
  • Phytotherapy Research published by John Wiley & Sons Ltd.
systematic-review
DOI

Khaled A et al. • Phytotherapy research : PTR (2023)

“More clinical trials are required before new natural compounds and herbs can be used to treat chronic hypertension and its ramifications, such as respiratory distress syndrome and kidney failure.© 2023 John Wiley & Sons, Ltd.”
Key Findings:
  • Alkaloids, amino acids, anthocyanidins, flavonoids, glucosinolates, isoflavonoids, phenolic acids, polyphenolics, and triterpenoids are among the bioactive metabolites pocessing an impressive ACE inhibitory activity.
  • Many herbs including Rosmarinus officinalis, Hibiscus sabdariffa, Curcuma longa, Rauwolfia serpentina, Emblica officinalis, Cynara scolymus, Punica granatum, Mucuna pruriens, Capsicum annuum, and Moringa olifera were found having ACE inhibitory activities comparable to captopril and enalpril.
  • These enticing natural ACE inhibitors deserve to be a safeguard medicine against hypertension, respiratory distress syndrome, and chronic kidney diseases.
  • More clinical trials are required before new natural compounds and herbs can be used to treat chronic hypertension and its ramifications, such as respiratory distress syndrome and kidney failure.© 2023 John Wiley & Sons, Ltd.
meta-analysis
DOI

Salekzamani S et al. • Phytotherapy research : PTR (2019)

“This meta-analysis provided convincing evidence for antioxidant activity of artichoke in animals.© 2018 John Wiley & Sons, Ltd.”
Key Findings:
  • Thirty-nine articles (two human, 23 animal, and 14 in vitro studies) were reviewed.
  • The results of in vitro systems supported the antioxidant effect of artichoke, whereas limited clinical trials indicated no change or a slight improvement of antioxidant status.
  • This meta-analysis provided convincing evidence for antioxidant activity of artichoke in animals.© 2018 John Wiley & Sons, Ltd.
38
Total Studies
8.7/10
Avg Quality
10-702
Sample Size Range
2003-2025
Research Span

Study Type Distribution

Systematic Review
17
RCT
11
Meta-Analysis
8
In Vitro
1
Crossover
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.